1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: a cancer journal for clinicians.2011;61(2): 69-90. [
DOI:10.3322/caac.20107] [
PMID]
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev V, Schmid H, Zattoni F. Guía de la EAU para el Cáncer de Próstata. Actas Urológicas Españolas 2009; 33(2):113-26.
https://doi.org/10.1016/S0210-4806(09)74110-5 [
DOI:10.4321/S0210-48062009000200004]
3. Turini M, Redaelli A, Gramegna P, Radice D. Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics. 2003;21(8):527-41. [
DOI:10.2165/00019053-200321080-00001] [
PMID]
4. Herna' ndez J, Thompson IM. Prostate-Specific Antigen: A Review of the Validation of the Most Commonly Used Cancer Biomarker. Cancer.2004;101:894-904. [
DOI:10.1002/cncr.20480] [
PMID]
5. Getzenberg RH, Partin AW. Prostate Cancer Tumor Markers.In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology. Philadelphia: Saunders-Elsevier; 2012:Chapter 98:2748-62. [
DOI:10.1016/B978-1-4160-6911-9.00098-0]
6. Inci M, Rifaioglu MM, Inci M, Celik M, Demir M, Ulutas T, et al. The Investigation of Total PSA, Free PSA, And Free/Total PSA Ratio in Patients With Liver Cirrhosis Patients According to Child-Pugh Score.Urology.2013;81(3):617-22. [
DOI:10.1016/j.urology.2012.11.022] [
PMID]
7. Vicentini FC, Botelho LAA, Hisano Marcelo, Ebaid GX, Lucon Marcos, Srouqi M. Are Total Prostate-specific Antigen Serum Levels in Cirrhotic Men Different From Those in Normal Men?. Urology.2009;73(5):1032-5. [
DOI:10.1016/j.urology.2009.01.015] [
PMID]
8. Cetinkaya M, Cetinkaya H, Ulusoy E, Baz S, Memiş A, Yaşa H, et al. Effect of Postnecrotic ana alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia.Prostate.1998;36(2):80-4.
https://doi.org/10.1002/(SICI)1097-0045(19980701)36:2<80::AID-PROS2>3.0.CO;2-I [
DOI:10.1002/(SICI)1097-0045(19980701)36:23.0.CO;2-I]
9. Williams PB, Eastham JA, Culkin DJ, Mata JA, Venable DD, Sartor O.Influence of Hepatic Function on Serum Levels of Prostate Specific Antigen. The Journal of Urology. 1997;158(5):1867-9. [
DOI:10.1016/S0022-5347(01)64149-1]
10. Bo J, Geoffrey WM, David JH. Fffects of Liver Disease and Transplantation on the Human Prostate. Journal of Andrology.1999;20(4):559-65.
11. Thuluvath PJ. Evaluation of Liver Transplant Recipients. Journal of Clinical and Experimental Hepatology.2011;1(3):199-203 [
DOI:10.1016/S0973-6883(11)60238-7]
12. Xavier T, Laurence C , Kerem G, Sophie H, Henri B, Arnaud D. Prostate carcinoma in liver transplant recipients : Think about it!. Urologic Oncology: Seminars and Original Investigations.2015;1-5.